This cancer is stubborn, but new drug regimen shows promise
Jan. 15, 2026, 11:54 a.m. ET Luciano Costa waited three years to see how patients with an aggressive bone-marrow cancer would fare on an experimental immunotherapy treatment. Reviewing the results gave him goose bumps. “Holy shit,” the oncologist thought. …